JANX
Janux Therapeutics, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Janux Therapeutics (JANX) Stock: Buy, Sell, or Hold?
$12.39
+0.35 (+2.91%)
▲
5d:
-31.85%
30d:
-27.88%
90d:
-22.56%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (83%)
Quality Score
51/100
Position
OVERSOLD
30-Day Fair Range
$15.56 – $18.38
Position: OVERSOLD
Forward P/E & Valuation
-4.8x
Next 12M consensus est.
Wall Street Target
$32.47
+162.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$11.59 / $18.62
Trend: Sideways
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: JANX is down 31.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Nov 2, 2026 at $17.52 · last confirmed Nov 9, 2026
Strength: 7.5/10
Get Alerted When JANX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: JANX is currently trading at $12.39, which is considered oversold relative to its 30-day fair value range of $15.56 to $18.38.
Technical Outlook: Technically, JANX is showing sideways momentum. Immediate support is located at $11.59, while resistance sits at $18.62.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $32.47 (+162.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, JANX is showing sideways momentum. Immediate support is located at $11.59, while resistance sits at $18.62.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $32.47 (+162.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$15.56 -
$18.38
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Trading Range & Key Levels
30-Day Trading Range
$15.56 -
$18.38
Current vs Trading Range
OVERSOLD
Support Level
$11.59
Resistance Level
$18.62
Current Trend
Sideways
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 162.0% below Wall St target ($32.47)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-4.84
Wall Street Target
$32.47
(+162.0%)
Revenue Growth (YoY)
-7.1%
Share JANX Analysis
Share this live JANX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (JANX)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Janux Therapeutics reported deep B-cell depletion in its initial Phase 1 trial of JANX011, causing a significant stock decline according to a bullish trader on StockTwits.
Key Retail Themes:
Company News
Clinical Trials
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 2:45 AM ET
Data refreshes hourly during market hours. Next update: 3:45 AM
Data refreshes hourly during market hours. Next update: 3:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is JANX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 35 SELL |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 38 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 31 SELL |
|
NAMS
NewAmsterdam Pharma Comp… |
STRONG BUY
16 analysts |
$50 | 44 HOLD |
|
IMUX
Immunic Inc |
STRONG BUY
13 analysts |
$43 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive JANX Research Pages
